Results

Bluebird Bio Inc.

09/21/2021 | Press release | Distributed by Public on 09/21/2021 14:24

bluebird bio Submits Biologics License Application (BLA) to FDA for betibeglogene autotemcel (beti-cel) Gene Therapy for Patients With β-thalassemia Who Require Regular Red[...]